Shah Gaurav

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$381,513.00
Insider Sells Quantity
11
Insider Sells Sum
$4.29M

Insider Activity of Shah Gaurav

According to the SEC Form 4 filings, Shah Gaurav, being in a position of

  1. CEO at Rocket Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 46834 shares for $724,428,
    over all time since 2019-03-01, has bought 22000 shares for $381,513, and sold 237989 shares for $4.29M.

The largest purchase of all time was on 2022-02-07 and amounted to 22000 shares of Rocket Pharmaceuticals, Inc. for $381,513.

The largest sale of all time was on 2019-03-04 and amounted to 49800 shares of Rocket Pharmaceuticals, Inc. for $860,544.

Biography of Shah Gaurav

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$724,4284100

Comparison of Insiders on Amount of Buys and Sells

2025-02-21SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
16,303
0.0149%
$10.58$172,486-17.39%
2024-11-21SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
11,091
0.0122%
$13.05$144,782-14.7%
2024-08-16SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
9,650
0.0105%
$18.50$178,564-27.52%
2024-05-16SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
9,790
0.0108%
$23.35$228,597-26.28%
2024-02-16SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
20,272
0.0224%
$29.84$604,876-34.52%
2023-08-17SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
4,767
0.006%
$15.47$73,750+49.9%
2023-05-17SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
4,122
0.0051%
$21.38$88,108+4.85%
2023-02-17SaleRocket Pharmaceuticals, Inc.
RCKT
CEO
12,194
0.015%
$19.06$232,418+2.36%
2022-02-07PurchaseRocket Pharmaceuticals, Inc.
RCKT
CEO
22,000
0.0339%
$17.34$381,513-6.75%
2019-03-05SaleRocket Pharmaceuticals, Inc.
RCKT
See Remarks
50,000
0.1136%
$16.90$845,000+0.61%
2019-03-04SaleRocket Pharmaceuticals, Inc.
RCKT
See Remarks
49,800
0.1083%
$17.28$860,544-6.3%
2019-03-01SaleRocket Pharmaceuticals, Inc.
RCKT
See Remarks
50,000
0.1087%
$17.12$856,000-5.61%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.